Efficacy of Oral Trigonella Foenum-graecum Seed Extract Vs Placebo in Treatment of None Alcoholic Fatty Liver Disease
Status:
Completed
Trial end date:
2017-09-01
Target enrollment:
Participant gender:
Summary
This study design to examine performance of trigonella foenum-graecum (TFG) in treatment of
non-alcoholic fatty liver disease. Base on inclusion and exclusion criteria, 50 patients
select and then randomize into intervention and control groups. Two group use capsules which
contain TFG or placebo, respectively.